Carregant...
Pharmacological eEF2K activation promotes cell death and inhibits cancer progression
Activation of the elongation factor 2 kinase (eEF2K) leads to the phosphorylation and inhibition of the elongation factor eEF2, reducing mRNA translation rates. Emerging evidence indicates that the regulation of factors involved in protein synthesis may be critical for controlling diverse biological...
Guardat en:
| Publicat a: | EMBO Rep |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5048377/ https://ncbi.nlm.nih.gov/pubmed/27572820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embr.201642194 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|